EIF2AK2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.652200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.132000E-01
Normal-vs-Stage2
3.853000E-01
Normal-vs-Stage3
5.184000E-01
Normal-vs-Stage4
3.568000E-01
Stage1-vs-Stage2
3.060600E-01
Stage1-vs-Stage3
4.459000E-01
Stage1-vs-Stage4
3.309800E-01
Stage2-vs-Stage3
1.834420E-01
Stage2-vs-Stage4
9.406200E-01
Stage3-vs-Stage4
1.881050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.007800E-01
Normal-vs-AfricanAmerican
2.508600E-01
Normal-vs-Asian
3.542000E-01
Caucasian-vs-AfricanAmerican
7.327000E-01
Caucasian-vs-Asian
2.116400E-01
AfricanAmerican-vs-Asian
6.737400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.890200E-01
Normal-vs-Female
4.420400E-01
Male-vs-Female
9.220200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.186000E-01
Normal-vs-Age(41-60Yrs)
3.140600E-01
Normal-vs-Age(61-80Yrs)
5.440000E-01
Normal-vs-Age(81-100Yrs)
7.451000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.831000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.472800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.001000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.564200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.076200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.270800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.097600E-01
Normal-vs-Daily Drinker
6.013000E-01
Normal-vs-Weekly Drinker
5.062600E-01
Normal-vs-Occasional Drinker
5.278200E-01
Normal-vs-Social Drinker
4.198000E-01
Non Drinker-vs-Daily Drinker
6.525600E-01
Non Drinker-vs-Weekly Drinker
4.282000E-01
Non Drinker-vs-Occasional Drinker
5.475000E-01
Non Drinker-vs-Social Drinker
2.955200E-01
Daily Drinker-vs-Weekly Drinker
7.881400E-01
Daily Drinker-vs-Occasional Drinker
9.332600E-01
Daily Drinker-vs-Social Drinker
6.595800E-01
Weekly Drinker-vs-Occasional Drinker
8.422000E-01
Weekly Drinker-vs-Social Drinker
8.856200E-01
Occasional Drinker-vs-Social Drinker
7.094800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.726970E-01
Normal-vs-Grade 2
5.776400E-02
Normal-vs-Grade 3
1.359560E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.89080000000087E-05
Grade 1-vs-Grade 3
2.13959999995073E-06
Grade 1-vs-Grade 4
1.726970E-01
Grade 2-vs-Grade 3
1.163030E-01
Grade 2-vs-Grade 4
5.776400E-02
Grade 3-vs-Grade 4
1.359560E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.891600E-01
Normal-vs-NonDiabetic
4.899000E-01
Diabetic-vs-NonDiabetic
5.799600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.658000E-01
Normal-vs-NoPancreatitis
5.147600E-01
Pancreatitis-vs-NoPancreatitis
4.908200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.313600E-01
Normal-vs-N1
3.827800E-01
N0-vs-N1
8.174300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.583760E-04
Normal-vs-TP53-NonMutant
3.622600E-01
TP53-Mutant-vs-TP53-NonMutant
3.87059999999995E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
